MEDIKINETICS


			The Butterfly Effect: Evaluating the Cardiovascular Impact of Diabetes Therapies Agenda 5:30 pm – Registration 6:00 pm – Dinner 6:30 pm – Welcome and Introduction 6:35 pm – Symposium 7:40 pm – Discussion 8:00 pm – Adjournment

The Butterfly Effect: Evaluating the Cardiovascular Impact of Diabetes Therapies

Type 2 diabetes is a metabolic condition marked by chronically elevated glucose levels leading to both micro- and macrovascular complications. Diabetes is associated with a two- to four-fold increase in cardiovascular disease. Heart disease is the leading cause of morbidity and mortality for patients with type 2 diabetes and is behind much of the financial burden of diabetes on the U.S. healthcare system.

A significant body of data has emerged over the years on the cardiovascular effects of medications prescribed for use in type 2 diabetes patients. Most recently, a meta-analysis has resulted in considerable uncertainty regarding the cardiovascular effects of a widely used diabetes compound. These initial findings have led medical professionals to re-examine currently available diabetes therapies, appropriate patient selection, and more closely monitor the results these medications may have on their type 2 diabetes patients.

It is critical that healthcare professionals involved in treating these patients understand the underlying cardiovascular risks inherent in this disease, and make use of the current data regarding diabetes treatments—administered independently or in combination—to realize the best possible overall glycemic and cardiovascular outcomes for their patients.

Educational Objectives:

At the end of the presentation, audience members should be able to:

Review the underlying cardiovascular risk inherent in diabetes.
Determine the different mechanisms of action and side effect profiles of the various classes of compounds and what differences exist within each class.
Discuss the apparent differences in cardiovascular outcomes observed between existing type 2 diabetes medications and the possible treatment ramifications these differences imply.

This course is designed for primary care physicians, PAs, nurses, nurse practitioners, pharmacists, and other healthcare professionals who want to expand their knowledge and experience in diabetes management.

Accreditation Information:

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Dannemiller Memorial Educational Foundation and MediKinetics LLC. The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.

The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists
Purdue University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Program Number (UPN): 018-999-07-203-L01-P, 1.5 contact hours (0.15 CEU).

Nurses
The Dannemiller Memorial Educational Foundation is an approved provider of the California Board of Registered Nursing. Provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.8 contact hours.

RNs outside California must verify with their licensing agency for approval of this course.

ADA Statement:

The Dannemiller Foundation and MediKinetics LLC fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in any of these educational activities is in need of accommodations, please contact us via e-mail at oferrell@medikinetics.net.

Faculty disclosure will be provided during the meeting.

Date / City	Faculty	Venue
January 9, 2008 San Francisco, CA	Carol H. Wysham, MD, FACE Assistant Clinical Professor of Medicine University of Washington Medical School Research Professor of Pharmacotherapy Washington State University	Sir Francis Drake Hotel Empire Ballroom 450 Powell Street
January 10, 2008 San Antonio, TX	Charles, F. Burant, MD, PhD Professor of Internal Medicine Director, Michigan Metabolomics and Obesity Center University of Michigan	The St. Anthony Hotel Anacacho Ballroom 300 East Travis Street
January 15, 2008 Memphis, TN	Charles, F. Burant, MD, PhD Professor of Internal Medicine Director, Michigan Metabolomics and Obesity Center University of Michigan	Hilton Memphis Southeast B/C 939 Ridge Lake Blvd.
January 22, 2008 Birmingham, AL	William T. Cefalu, MD Professor and Chief Division of Nutrition and Chronic Diseases Pennington Biomedical Research Center Louisiana State University	Sheraton Birmingham Birmingham 3 & 4 2101 Richard Arrington Jr. Blvd. N.
January 24, 2008 Ft. Lauderdale, FL	Ronald Goldberg, MD Professor of Medicine, Biochemistry and Molecular Biology Division of Endocrinology, Diabetes and Metabolism University of Miami Miller School of Medicine	Hilton Ft. Lauderdale Del Sol Ballroom 505 N. Ft. Lauderdale Beach Blvd.
February 12, 2008 Washington, DC	John B. Buse, MD, PhD Chief, Division of General Medicine Director, Diabetes Care Center University of North Carolina	Renaissance Washington, DC Congressional Ballroom A/B 999 Ninth Street NW
February 13, 2008 San Diego, CA	Robert Henry, M.D. Chief, Section of Endocrinology, Diabetes, and Metabolism Veterans Affairs Medical Center Professor of Medicine University of California, San Diego	Westin Horton Plaza California Room 910 Broadway Circle
February 20, 2008 Atlanta, GA	John B. Buse, MD, PhD Chief, Division of General Medicine Director, Diabetes Care Center University of North Carolina	Westin Peachtree Atlanta Atlanta CDEF 210 Peachtree St.
February 26, 2008 Portland, OR	Carol H. Wysham, MD, FACE Assistant Clinical Professor of Medicine University of Washington Medical School Research Professor of Pharmacotherapy Washington State University	The Governor Hotel Grand Ballroom 614 SW 11th Avenue
February 28, 2008 Cincinnati, OH	Byron Hoogwerf, MD, FACE Professor of Medicine Program Director, Internal Medicine Residency Program Cleveland Clinic Health Services Center	The Phoenix Grand Ballroom 812 Race St.
March 5, 2008 Chicago, IL	Charles F. Burant, MD, PhD Professor of Internal Medicine Director, Michigan Metabolomics and Obesity Center University of Michigan	Westin Chicago River North Astor Room 320 N. Dearborn Street
March 13, 2008 Kansas City, MO	Robert Henry, MD. Chief, Section of Endocrinology, Diabetes, and Metabolism Veterans Affairs Medical Center Professor of Medicine University of California, San Diego	Hyatt Regency Crown Center Empire Ballroom 2345 McGee Street
March 19, 2008 New York, NY	Mandeep Bajaj, MD Associate Professor of Medicine Division of Diabetes, Endocrinology and Metabolism Baylor College of Medicine	The Manhattan Club at Rosie O'Grady's 800 7th Avenue
March 25, 2008 Minneapolis, MN	Robert Henry, MD Chief, Section of Endocrinology, Diabetes, and Metabolism Veterans Affairs Medical Center Professor of Medicine University of California, San Diego	Millennium Minneapolis Loring Ballroom 1313 Nicollet Mall
March 26, 2008 Pittsburgh, PA	Mary Korytkowski, MD Professor of Medicine University of Pittsburgh School of Medicine	Omni William Penn Hotel Urban Room 530 William Penn Place

Click here to proceed to the registration page.


		Supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

		Jointly sponsored by Dannemiller Memorial Educational Foundation
		and MediKinetics^TM

		There is no fee to participate in this activity.